| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 129.014 | 79 |
| GSM780708 | Untreated after 4 days (C2_1) | 95.5446 | 75 |
| GSM780709 | Untreated after 4 days (C3_1) | 88.2506 | 73 |
| GSM780719 | Untreated after 4 days (C1_2) | 117.806 | 77 |
| GSM780720 | Untreated after 4 days (C2_2) | 118.236 | 78 |
| GSM780721 | Untreated after 4 days (C3_2) | 106.149 | 76 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 95.5819 | 75 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 100.034 | 75 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 104.921 | 76 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 99.6816 | 75 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 109.886 | 77 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 121.543 | 78 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 103.175 | 76 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 91.6622 | 74 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 94.5996 | 74 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 128.071 | 79 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 102.753 | 76 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 123.794 | 78 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 120.241 | 78 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 96.3519 | 75 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 112.856 | 77 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 122.326 | 78 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 106.657 | 76 |